{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:13:19Z","timestamp":1791231199810,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.ejim.2007.06.036","type":"journal-article","created":{"date-parts":[[2008,4,17]],"date-time":"2008-04-17T22:02:00Z","timestamp":1208469720000},"page":"602-607","source":"Crossref","is-referenced-by-count":45,"title":["Relation between hemostatic parameters and prognostic\/predictive factors in breast cancer"],"prefix":"10.1016","volume":"19","author":[{"given":"Engin","family":"Yigit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fczin","family":"G\u00f6n\u00fcll\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130dris","family":"Y\u00fccel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Turgut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilek","family":"Erdem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burcu","family":"\u00c7akar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2007.06.036_bb0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/canjclin.50.1.7","article-title":"Cancer statistics, 2000","volume":"50","author":"Greenlee","year":"2000","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejim.2007.06.036_bb0010","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/1097-0142(19900715)66:2<331::AID-CNCR2820660222>3.0.CO;2-6","article-title":"DNA index and S-phase fraction and their combinations as prognostic factors in operable ductal breast carcinoma","volume":"66","author":"Joensuu","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.ejim.2007.06.036_bb0015","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1200\/JCO.1992.10.5.686","article-title":"Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features","volume":"10","author":"Gasparini","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejim.2007.06.036_bb0020","first-page":"885","article-title":"Determination of the prognostic value of cyclin D1 overexpression in breast cancer","volume":"11","author":"Mclntosh","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.ejim.2007.06.036_bb0025","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0959-8049(00)00395-6","article-title":"c-erbB-2 positivity is a factor for poor prognosis in breast cancer and poor response to hormonal or chemotherapy treatment in advanced disease","volume":"37","author":"Jukkola","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejim.2007.06.036_bb0030","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/annonc\/mdg197","article-title":"Prognostic value of p53 molecular status in high-risk primary breast cancer","volume":"14","author":"Marchetti","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejim.2007.06.036_bb0035","first-page":"2505","article-title":"Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer","volume":"61","author":"Geisler","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejim.2007.06.036_bb0040","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/jnci\/djg101","article-title":"Hemostatic regulators of tumor angiogenesis: a source of antiangiogenic agents for cancer treatment?","volume":"95","author":"Daly","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejim.2007.06.036_bb0045","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/sj.neo.7900184","article-title":"The hemostatic system and angiogenesis in malignancy","volume":"3","author":"Wojtukiewicz","year":"2001","journal-title":"Neoplasia"},{"key":"10.1016\/j.ejim.2007.06.036_bb0050","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-2004-822967","article-title":"Contribution of the hemostatic system to angiogenesis in cancer","volume":"30","author":"Wojtukiewicz","year":"2004","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.ejim.2007.06.036_bb0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF00047657","article-title":"Role of plasma, platelets, and endothelial cells in tumor metastasis","volume":"3","author":"Gasic","year":"1984","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.ejim.2007.06.036_bb0060","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/jnci\/91.1.22","article-title":"Inhibition of metastases by anticoagulants","volume":"91","author":"Hejna","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejim.2007.06.036_bb0065","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1055\/s-0037-1613579","article-title":"Systemic coagulation reactivation in recurrence of colorectal cancer","volume":"89","author":"Iversen","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2007.06.036_bb0070","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1470-2045(01)00619-2","article-title":"Cancer and the prothrombotic state","volume":"3","author":"Lip","year":"2002","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejim.2007.06.036_bb0075","first-page":"391","article-title":"Hemostatic abnormalities associated with cancer and its therapy","volume":"27","author":"Glassman","year":"1997","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.ejim.2007.06.036_bb0080","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0945-053X(00)00079-2","article-title":"Effects of thrombin\/thrombosis in angiogenesis and tumour progression","volume":"19","author":"Maragoudakis","year":"2000","journal-title":"Matrix Biol"},{"key":"10.1016\/j.ejim.2007.06.036_bb0085","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF03187336","article-title":"Coagulation and cancer: implications for diagnosis and management","volume":"6","author":"Loreto","year":"2000","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.ejim.2007.06.036_bb0090","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1161\/01.CIR.0000078466.72504.AC","article-title":"Venous thromboembolism and cancer: risks and outcomes","volume":"107","author":"Lee","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2007.06.036_bb0095","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1182\/blood.V96.10.3302","article-title":"Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells","volume":"96","author":"Palumbo","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2007.06.036_bb0100","first-page":"37","article-title":"Role of the coagulation system in tumor-cell-induced platelet aggregation and metastasis","volume":"18","author":"Cavanaugh","year":"1988","journal-title":"Haemostasis"},{"key":"10.1016\/j.ejim.2007.06.036_bb0105","first-page":"303","article-title":"The role of thrombin in tumor cell metastasis","volume":"14","author":"Walz","year":"1994","journal-title":"Invasion Metastasis"},{"key":"10.1016\/j.ejim.2007.06.036_bb0110","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0959-8049(96)00310-3","article-title":"Haemostatic abnormalities in lung cancer: prognostic implications","volume":"33","author":"Buccheri","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejim.2007.06.036_bb0115","first-page":"168","article-title":"Evaluation of the coagulation\/fibrinolysis balance in patients with colorectal cancer","volume":"23","author":"van Duijnhoven","year":"1993","journal-title":"Haemostasis"},{"key":"10.1016\/j.ejim.2007.06.036_bb0120","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1055\/s-0037-1613296","article-title":"Coagulation markers predict survival in cancer patients","volume":"88","author":"Beer","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2007.06.036_bb0125","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0090-4295(03)00768-4","article-title":"Tissue factor expression and prognosis in patients with metastatic prostate cancer","volume":"62","author":"Akashi","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.ejim.2007.06.036_bb0130","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0304-3835(99)00230-X","article-title":"Activation of blood coagulation and the activity of cancer procoagulant (EC 3.4.22.26) in breast cancer patients","volume":"146","author":"Mielicki","year":"1999","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ejim.2007.06.036_bb0135","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/00001721-199304000-00006","article-title":"Activation of coagulation and fibrinolysis in patients with lung cancer: relation to tumour stage and prognosis","volume":"4","author":"Seitz","year":"1993","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.ejim.2007.06.036_bb0140","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/sj.bjc.6600069","article-title":"Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer","volume":"86","author":"Dirix","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejim.2007.06.036_bb0145","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1748-5827.1999.tb03090.x","article-title":"Correlation of haemostatic abnormalities with tumour stage and characteristics in dogs with mammary carcinoma","volume":"40","author":"Stockhaus","year":"1999","journal-title":"J Small Anim Pract"},{"key":"10.1016\/j.ejim.2007.06.036_bb0150","first-page":"112","article-title":"Activated-protein-C resistance in cancer patients","volume":"27","author":"Green","year":"1997","journal-title":"Haemostasis"},{"key":"10.1016\/j.ejim.2007.06.036_bb0155","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0277-5379(85)90265-2","article-title":"Hemostatic alterations are unrelated to the stage of tumor in untreated malignant melanoma and breast carcinoma","volume":"21","author":"Mannucci","year":"1985","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1016\/j.ejim.2007.06.036_bb0160","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1158\/0008-5472.CAN-03-1957","article-title":"Microvessel density as a prognostic factor in women with breast cancer. A systematic review of the literature and meta-analysis","volume":"64","author":"Uzan","year":"2004","journal-title":"Cancer Research"},{"key":"10.1016\/j.ejim.2007.06.036_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199101033240101","article-title":"Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma","volume":"324","author":"Weidner","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2007.06.036_bb0170","first-page":"87","article-title":"Factor VIIIR: Ag plasma levels in patients with cervical and ovarian carcinoma","volume":"9","author":"Facchini","year":"1988","journal-title":"Eur J Oncol"},{"key":"10.1016\/j.ejim.2007.06.036_bb0175","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1006\/gyno.1993.1139","article-title":"Pretreatment plasma level of fibrinopeptide-A (FPA), D-dimer (DD), and von Willebrand factor (vWF) in patients with operable cervical cancer: influence of surgical\u2013pathological stage, tumor size, histologic type, and lymph node status","volume":"49","author":"Gadducci","year":"1993","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejim.2007.06.036_bb0180","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0049-3848(99)00041-9","article-title":"von Willebrand factor in plasma of patients with advanced stages of larynx cancer","volume":"95","author":"Paczuski","year":"1999","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejim.2007.06.036_bb0185","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI114976","article-title":"Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo","volume":"87","author":"Nierodzik","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejim.2007.06.036_bb0190","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1590\/S0100-879X2001000900004","article-title":"von Willebrand factor antigen levels in plasma of patients with malignant breast disease","volume":"34","author":"Rohsig","year":"2001","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.ejim.2007.06.036_bb0195","first-page":"331","article-title":"Usefulness of coagulation markers in staging of gastric cancer","volume":"19","author":"Abbasciano","year":"1995","journal-title":"Cancer Detect Prev"},{"key":"10.1016\/j.ejim.2007.06.036_bb0200","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/bjs.1800840212","article-title":"Fibrinogen levels correlate with stage of disease in patients with esophageal cancer","volume":"84","author":"Wayman","year":"1997","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejim.2007.06.036_bb0205","first-page":"266","article-title":"A randomized clinical trial of combination chemotherapy with and without low- molecular-weight heparin in small cell lung cancer","volume":"21","author":"Altinbas","year":"2004","journal-title":"J Thromb Haemost."},{"key":"10.1016\/j.ejim.2007.06.036_bb0210","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/mpo.2950080408","article-title":"The relevance of platelet and fibrinogen kinetics and coagulation studies to extent of disease and performance status in patients with adenocarcinoma","volume":"8","author":"Williams","year":"1980","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.ejim.2007.06.036_bb0215","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1200\/JCO.2000.18.3.600","article-title":"Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status","volume":"18","author":"Blackwell","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejim.2007.06.036_bb0220","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00001721-200401000-00002","article-title":"Comparison of plasma D-dimer and thrombus precursor protein in patients with operable breast cancer as a potential predictor of lymph node metastasis","volume":"15","author":"Kim","year":"2004","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.ejim.2007.06.036_bb0225","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/030089169307900513","article-title":"Plasma D-dimer measurement as a marker of gynecological tumors: comparison with CA 125","volume":"79","author":"Rella","year":"1993","journal-title":"Tumori"},{"key":"10.1016\/j.ejim.2007.06.036_bb0230","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF01625435","article-title":"Plasma levels of D-dimer: a crosslinked fibrin-degradation product in female breast cancer","volume":"117","author":"Mitter","year":"1991","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ejim.2007.06.036_bb0235","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.rmed.2003.07.001","article-title":"Prognostic significance of hemostatic parameters in patients with lung cancer","volume":"98","author":"Unsal","year":"2004","journal-title":"Respir Med"},{"key":"10.1016\/j.ejim.2007.06.036_bb0240","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1021\/bi962446r","article-title":"Human fibroblast adhesion to fibrinogen","volume":"36","author":"Farrel","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejim.2007.06.036_bb0245","first-page":"37","article-title":"Role of the coagulation system in tumor-cell-induced platelet aggregation and metastasis","volume":"18","author":"Cavanaugh","year":"1988","journal-title":"Haemostasis"},{"key":"10.1016\/j.ejim.2007.06.036_bb0250","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ajh.20546","article-title":"Roles of protein C, protein S, and antithrombin III in acute leukemia","volume":"81","author":"Dixit","year":"2006","journal-title":"Am J Hematol."},{"key":"10.1016\/j.ejim.2007.06.036_bb0255","doi-asserted-by":"crossref","first-page":"17635","DOI":"10.1074\/jbc.M603094200","article-title":"The constitutive expression of anticoagulant protein S is regulated through multiple binding sites for Sp1 and Sp3 transcription factors in the protein S gene promoter","volume":"281","author":"de Wolf","year":"2006","journal-title":"J Biol Chem"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620508000782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620508000782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T13:36:58Z","timestamp":1588599418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620508000782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0953620508000782"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2007.06.036","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}